We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$491M
AUM Growth
-$1.05B
Cap. Flow
-$1.12B
Cap. Flow %
-228.79%
Top 10 Hldgs %
14.65%
Holding
648
New
56
Increased
90
Reduced
399
Closed
62

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.3M
2
STT icon
State Street
STT
+$1.21M
3
BALL icon
Ball Corp
BALL
+$1.18M
4
TGT icon
Target
TGT
+$1.04M
5
CCL icon
Carnival Corporation Ltd
CCL
+$955K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$51.4M
2
V icon
Visa
V
+$42.4M
3
MRK icon
Merck
MRK
+$41.1M
4
NKE icon
Nike
NKE
+$40.8M
5
DIS icon
Walt Disney
DIS
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Financials 16.02%
3 Healthcare 14.4%
4 Consumer Discretionary 11.41%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
101
MSCI
MSCI
$41B
$1.09M 0.22%
4,212
-3,525
-46% -$859K
CCL icon
102
Carnival Corporation Ltd
CCL
$39.7B
$1.09M 0.22%
+21,367
New +$955K
CSX icon
103
CSX Corp
CSX
$93B
$1.07M 0.22%
44,550
-16,350
-27% -$387K
MS icon
104
Morgan Stanley
MS
$339B
$1.07M 0.22%
21,000
-19,250
-48% -$911K
ROK icon
105
Rockwell Automation
ROK
$48.9B
$1.07M 0.22%
5,284
-5,600
-51% -$1.04M
SNPS icon
106
Synopsys
SNPS
$79.7B
$1.07M 0.22%
7,675
-6,775
-47% -$929K
ZTS icon
107
Zoetis
ZTS
$30.5B
$1.06M 0.22%
8,025
-22,625
-74% -$2.81M
WDC icon
108
Western Digital
WDC
$150B
$1.05M 0.21%
21,962
+5,094
+30% +$213K
CDW icon
109
CDW
CDW
$17B
$1.05M 0.21%
7,325
-5,525
-43% -$731K
CVX icon
110
Chevron
CVX
$365B
$1.04M 0.21%
8,669
-17,710
-67% -$2.09M
LIN icon
111
Linde
LIN
$226B
$1.04M 0.21%
4,900
-8,275
-63% -$1.67M
AON icon
112
Aon
AON
$75.7B
$1.04M 0.21%
4,996
-9,950
-67% -$1.97M
Y
113
DELISTED
Alleghany Corp
Y
$1.04M 0.21%
1,300
-100
-7% -$78.1K
CL icon
114
Colgate-Palmolive
CL
$74.2B
$1.04M 0.21%
15,075
-379,521
-96% -$25.9M
MCK icon
115
McKesson
MCK
$102B
$1.04M 0.21%
7,500
+50
+0.7% +$7.07K
KEY icon
116
KeyCorp
KEY
$24.4B
$1.04M 0.21%
51,165
-33,800
-40% -$638K
BIIB icon
117
Biogen
BIIB
$30.7B
$1.03M 0.21%
3,475
-3,975
-53% -$1.1M
ABBV icon
118
AbbVie
ABBV
$434B
$1.02M 0.21%
11,562
-253,625
-96% -$21.1M
HAL icon
119
Halliburton
HAL
$26.6B
$1.02M 0.21%
41,600
-26,650
-39% -$562K
GD icon
120
General Dynamics
GD
$106B
$1.01M 0.21%
5,750
-725
-11% -$130K
TRMB icon
121
Trimble
TRMB
$13.9B
$1.01M 0.21%
24,200
+9,950
+70% +$396K
NEM icon
122
Newmont
NEM
$119B
$1.01M 0.2%
23,147
-12,350
-35% -$483K
NOC icon
123
Northrop Grumman
NOC
$81.1B
$1.01M 0.2%
2,925
-2,450
-46% -$862K
BNY
124
Bank of New York Mellon
BNY
$107B
$1M 0.2%
+19,950
New +$952K
CDNS icon
125
Cadence Design Systems
CDNS
$93.3B
$1M 0.2%
14,450
-12,500
-46% -$838K

Similar funds

Oakbrook Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Oakbrook Investments held 648 positions worth $491M, down 68% from $1.54B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oakbrook Investments withdrew a net $1.12B in Q4 2019, closing 62 positions and reducing 399 holdings. Its most notable exit was 3M, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Oakbrook Investments opened a new position in State Street worth $1.36M.

  • Oakbrook Investments's largest Q4 2019 buy was State Street: 17,250 shares worth $1.36M.
  • Oakbrook Investments added most to Pfizer in Q4 2019, an estimated $1.3M increase.
  • Oakbrook Investments's biggest Q4 2019 reduction was Apple, cutting an estimated $51.4M.
  • Oakbrook Investments fully exited 3M in Q4 2019, selling an estimated $22.6M.
  • Oakbrook Investments's ten largest holdings make up 15% of its $491M portfolio in Q4 2019.
  • Oakbrook Investments opened 56 new positions and closed 62 in Q4 2019.
  • Oakbrook Investments's portfolio value fell 68% quarter-over-quarter to $491M.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.